[go: up one dir, main page]

DK3085777T3 - Polypeptid - Google Patents

Polypeptid Download PDF

Info

Publication number
DK3085777T3
DK3085777T3 DK16172568.4T DK16172568T DK3085777T3 DK 3085777 T3 DK3085777 T3 DK 3085777T3 DK 16172568 T DK16172568 T DK 16172568T DK 3085777 T3 DK3085777 T3 DK 3085777T3
Authority
DK
Denmark
Prior art keywords
polypeptide
Prior art date
Application number
DK16172568.4T
Other languages
English (en)
Inventor
Martin Johannes Loessner
Fritz Eichenseher
Original Assignee
Micreos Human Health Bv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=44626456&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK3085777(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Micreos Human Health Bv filed Critical Micreos Human Health Bv
Application granted granted Critical
Publication of DK3085777T3 publication Critical patent/DK3085777T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14Hydrolases (3)
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14Hydrolases (3)
    • C12N9/24Hydrolases (3) acting on glycosyl compounds (3.2)
    • C12N9/2402Hydrolases (3) acting on glycosyl compounds (3.2) hydrolysing O- and S- glycosyl compounds (3.2.1)
    • C12N9/2462Lysozyme (3.2.1.17)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/02Local antiseptics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/305Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Micrococcaceae (F)
    • C07K14/31Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Micrococcaceae (F) from Staphylococcus (G)
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/11DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56911Bacteria
    • G01N33/56938Staphylococcus
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • General Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Biophysics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Physics & Mathematics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Food Science & Technology (AREA)
  • Pathology (AREA)
  • General Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Cell Biology (AREA)
DK16172568.4T 2011-05-04 2011-05-04 Polypeptid DK3085777T3 (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP11720345.5A EP2705144B2 (en) 2011-05-04 2011-05-04 A polypeptide
PCT/NL2011/050307 WO2012150858A1 (en) 2011-05-04 2011-05-04 A polypeptide
EP16172568.4A EP3085777B1 (en) 2011-05-04 2011-05-04 A polypeptide

Publications (1)

Publication Number Publication Date
DK3085777T3 true DK3085777T3 (da) 2020-02-03

Family

ID=44626456

Family Applications (2)

Application Number Title Priority Date Filing Date
DK11720345.5T DK2705144T4 (da) 2011-05-04 2011-05-04 Polypeptid
DK16172568.4T DK3085777T3 (da) 2011-05-04 2011-05-04 Polypeptid

Family Applications Before (1)

Application Number Title Priority Date Filing Date
DK11720345.5T DK2705144T4 (da) 2011-05-04 2011-05-04 Polypeptid

Country Status (15)

Country Link
US (2) US9382298B2 (da)
EP (2) EP2705144B2 (da)
JP (1) JP6261086B2 (da)
KR (1) KR101911114B1 (da)
CN (2) CN108192902A (da)
AU (1) AU2011367262B2 (da)
BR (1) BR112013028251B1 (da)
CA (1) CA2834924C (da)
DK (2) DK2705144T4 (da)
ES (2) ES2768777T3 (da)
HK (1) HK1195791A1 (da)
IL (1) IL229247B (da)
PL (2) PL3085777T3 (da)
SG (1) SG194776A1 (da)
WO (1) WO2012150858A1 (da)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9206411B2 (en) * 2012-06-13 2015-12-08 The United States Of America, As Represented By The Secretary Of Agriculture Staphylococcal Phage2638A endolysin amidase domain is lytic for Staphylococcus aureus
WO2015005787A1 (en) 2013-07-11 2015-01-15 Micreos Human Health B.V. Combination treatment for atopic dermatitis
CN106795506B (zh) 2014-05-14 2020-11-27 达特茅斯学院理事会 去免疫化溶葡萄球菌酶和使用方法
CN107580503B (zh) * 2015-03-12 2021-07-09 迈克瑞欧斯人体健康有限公司 用于治疗细菌感染的杀菌剂与亲溶酶体碱化剂的组合
DK3144387T3 (da) * 2015-09-15 2018-04-30 Micreos Human Health Bv Nyt endolysinpolypeptid
US20200291373A1 (en) 2017-10-06 2020-09-17 Micreos Human Health B.V. Treatment of a Condition Associated with Infection with an Oncogenic Bacterium
CN112118861A (zh) * 2018-02-26 2020-12-22 康特拉费克特公司 修饰的PlySs2溶素及其用途
JP7454211B2 (ja) * 2020-01-20 2024-03-22 日本全薬工業株式会社 バクテリオファージ由来エンドライシン
IL296529A (en) 2020-03-19 2022-11-01 Micreos Human Health Bv A stabilized protein of interest
CA3175923A1 (en) * 2020-04-20 2021-10-28 Fritz Eichenseher A chimeric endolysin polypeptide.
WO2023049243A1 (en) * 2021-09-22 2023-03-30 Biomedit, Llc Lysostaphin variants and methods of use thereof
WO2024241070A1 (en) 2023-05-22 2024-11-28 L'oreal Cosmetic composition comprising an endolysin and a polyvinyl alcohol
WO2024246325A1 (en) 2023-06-02 2024-12-05 L'oreal Cosmetic composition comprising an endolysin derived from a staphylococcus aureus phage and an aromatic alcohol
FR3149209A1 (fr) 2023-06-02 2024-12-06 L'oreal Composition cosmétique comprenant une endolysine dérivée de phage de Staphylococcus aureus et un alcool aromatique
FR3149206A1 (fr) 2023-06-02 2024-12-06 L'oreal Composition cosmétique aqueuse comprenant une endolysine et du tréhalose
FR3149203A1 (fr) 2023-06-02 2024-12-06 L'oreal Composition anhydre comprenant une endolysine et de l’hydroxypropylmethylcellulose et/ou du pullulane
FR3149205A1 (fr) 2023-06-02 2024-12-06 L'oreal Composition cosmétique comprenant une endolysine et un agent de charge organique
FR3149201A1 (fr) 2023-06-02 2024-12-06 L'oreal Composition cosmétique anhydre comprenant une endolysine dérivée de phage de Staphylococcus aureus et du mannitol.
FR3149202A1 (fr) 2023-06-02 2024-12-06 L'oreal Composition cosmétique comprenant une endolysine dérivée de phage de Staphylococcus aureus et une huile.
FR3149208A1 (fr) 2023-06-02 2024-12-06 L'oreal Composition cosmétique, notamment aqueuse, comprenant une endolysine et un pullulane
FR3152395A1 (fr) 2023-08-28 2025-03-07 L'oreal Composition cosmétique comprenant une endolysine dérivée de phage de Staphylococcus aureus et la 4-hydroxyacetophenone
FR3149207A1 (fr) 2023-06-02 2024-12-06 L'oreal Composition cosmétique comprenant une endolysine et un composé de formule (I)
FR3149204A1 (fr) 2023-06-02 2024-12-06 L'oreal Composition cosmétique comprenant une endolysine et un tensioactif non ionique comprenant un résidu carbohydrate
FR3152394A1 (fr) 2023-08-28 2025-03-07 L'oreal Composition cosmétique comprenant une endolysine et des particules d’aérogel de silice hydrophobe
FR3152396A1 (fr) 2023-08-28 2025-03-07 L'oreal Composition cosmétique comprenant une endolysine dérivée de phage de Staphylococcus aureus et un polyhydroxyalcane
FR3152393A1 (fr) 2023-08-28 2025-03-07 L'oreal Composition cosmétique comprenant une endolysine dérivée d’un phage de Staphylococcus aureus et une charge minérale

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8058225B2 (en) * 2007-08-22 2011-11-15 Hyglos Invest Gmbh Proteins for use in human and animal Staphylococcus infections
JP5758291B2 (ja) * 2008-07-03 2015-08-05 ザ ロックフェラー ユニバーシティ Staphylococcibacteriaに対する活性を有するキメラバクテリオファージ溶解素
AU2009273845B2 (en) 2008-07-24 2016-02-04 The United State Of America, As Represented By The Secretary Of Agriculture Triple acting antimicrobials that are refractory to resistance development
EP2157100A1 (en) 2008-08-19 2010-02-24 Profos AG Artificial peptidoglycan lysing enzymes and peptidoglycan binding proteins
US9534223B2 (en) * 2010-04-27 2017-01-03 Lysando Ag Method of reducing biofilms
EP2702070B1 (en) 2011-04-27 2015-09-30 Lysando AG New antimicrobial agents

Also Published As

Publication number Publication date
US20140127168A1 (en) 2014-05-08
ES2768777T3 (es) 2020-06-23
DK2705144T3 (da) 2016-09-05
EP3085777B1 (en) 2019-11-06
ES2589784T5 (es) 2020-04-21
KR20140066976A (ko) 2014-06-03
US9382298B2 (en) 2016-07-05
WO2012150858A1 (en) 2012-11-08
BR112013028251B1 (pt) 2021-04-06
KR101911114B1 (ko) 2018-10-23
HK1195791A1 (zh) 2014-11-21
ES2589784T3 (es) 2016-11-16
BR112013028251A2 (pt) 2017-01-17
SG194776A1 (en) 2013-12-30
PL2705144T3 (pl) 2016-12-30
AU2011367262A1 (en) 2013-11-21
EP2705144B2 (en) 2019-08-28
US20160369255A1 (en) 2016-12-22
US10174300B2 (en) 2019-01-08
DK2705144T4 (da) 2019-10-21
EP3085777A1 (en) 2016-10-26
EP2705144B1 (en) 2016-06-08
CA2834924C (en) 2022-08-16
CN108192902A (zh) 2018-06-22
PL3085777T3 (pl) 2020-05-18
EP2705144A1 (en) 2014-03-12
AU2011367262B2 (en) 2016-11-03
IL229247A0 (en) 2014-01-30
IL229247B (en) 2019-03-31
CA2834924A1 (en) 2012-11-08
JP6261086B2 (ja) 2018-01-17
JP2014519815A (ja) 2014-08-21
CN103703127A (zh) 2014-04-02

Similar Documents

Publication Publication Date Title
DK2705144T4 (da) Polypeptid
DK2728002T3 (da) Heterodimeriseret polypeptid
DK2940135T3 (da) Heterodimeriseret polypeptid
CO7020866A2 (es) Péptidos terapéuticos
BR112014004902A2 (pt) peptídeos
CO6900146A2 (es) Imidazopiridazinas sustituidas con amino
DK2797616T3 (da) Celle-penetrerende peptider
BR112013017629A2 (pt) laminina-521 recombinante
BR112013020613A2 (pt) autoinjetor
CO6862104A2 (es) Inmunotoxina recombinante dirigida a la mesotelina
EP2791034A4 (en) Transport apparatus
HUE040326T2 (hu) Mutáns interleukon-2 polipeptidek
SG11201400432VA (en) Polypeptide vaccine
FI20116181L (fi) Uusia terapeuttisia vektoreita
EP2794701A4 (en) A peptide-hydrogel composite
IL231616A0 (en) Tropicalizing agent
DK3384944T3 (da) Autoinjektor
PL2663506T3 (pl) Zamknięcie
FI20116212L (fi) Polypeptidi
BR112014000879A2 (pt) deflegmador
DE102011100082A8 (de) Traygreifvorrichtung
CO6960543A2 (es) 2-tiopirimidinonas
EP2812347A4 (en) PEPTIDE INDUCING AUTOPHAGIA
FR2988733B1 (fr) Microorganisme recombinant
BR112013029769A2 (pt) levedura recombinante